医学
干细胞
神经科学
干细胞疗法
癫痫
细胞疗法
生物信息学
重症监护医学
临床试验
干细胞生物学
个性化医疗
转化研究
精密医学
诱导多能干细胞
评论文章
临床前研究
基因组编辑
作者
Napasiri Putthanbut,Jea-Young Lee,Cesar V. Borlongan
标识
DOI:10.1093/stcltm/szag077
摘要
Epilepsy represents as one of the most prevalent and serious neurological disorders, with approximately one-third of patients resistant to conventional treatments. Current pharmacologic therapies primarily suppress seizures without targeting the underlying epileptogenesis, resulting in unchanged long-term prognosis. At the same time, epilepsy surgery remains underutilized due to the requirement for extensive evaluations and specialized expertise. Stem cell-based therapy has emerged as a promising avenue, offering the potential to address both the neurological and neuropsychiatric aspects. This review summarizes recent preclinical and clinical studies on stem cell therapy in epilepsy, with a focus on their mechanisms of action, including direct engraftment, restoration of normal neurogenesis, and immunomodulation via bystander effect. Advances in genetic engineering, extracellular vesicle-based therapy, and patient-derived brain organoids offer more personalized treatment strategies. Although stem cell therapy holds significant promise as a treatment for epilepsy, further extensive research is required to establish its clinical safety and efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI